SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-018531
Filing Date
2022-07-05
Accepted
2022-07-05 16:15:27
Documents
1
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1525
  Complete submission text file 0001493152-22-018531.txt   3081
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENVERIC BIOSCIENCES, INC., 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address
O'NEIL BEVIN (Reporting) CIK: 0001936294 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38286 | Film No.: 221065060